Changes in Hong Kong stocks | Jinhai Medical Technology (02225) rose more than 18% in early trading, and the company was included in the Hong Kong Stock Connect list, and the revenue structure for the first half of the year was significantly optimized

The Zhitong Finance App learned that Jinhai Medical Technology (02225) rose more than 18% in early trading. As of press release, it rose 15.60% to HK$4.855, with a turnover of HK$578.683 million.

According to the news, on September 7, the Shenzhen Stock Exchange announced that according to the relevant provisions of the “Shenzhen Stock Exchange Shenzhen-Hong Kong Stock Exchange Business Implementation Measures”, Hong Kong Stock Exchange's securities list has been adjusted and will take effect from September 7. Among them, Jinhai Medical Technology was included in the Hong Kong Stock Connect list. This inclusion will help broaden the shareholder base, attract long-term institutional investors, and enhance the liquidity of share transactions.

It is worth noting that in the first half of the year, Jinhai Medical Technology's revenue structure was significantly optimized, and the strategic focus has successfully shifted from traditional labor services to a high-value-added medical device circuit. The share of revenue from minimally invasive surgical solutions, medical products and related service fees has climbed to 74.73%, making it a well-deserved new revenue pillar. Following a good increase in medical device sales revenue in 2025, the business's revenue surged 301.5% year-on-year in the first half of 2026 to reach SG$25.427 million, with sufficient momentum for sustainable growth.